AT-II-receptor antagonists include losartan, valsartan, irbesartan, candesartan, eprosartan, telmisartan, and tasosartan. Several clinical trials have demonstrated that AT-II-receptor antagonists ...

Six ARBs are currently available in the United States for hypertension: losartan, valsartan, irbesartan, candesartan, eprosartan, and telmisartan (Table 1). All ARBs share certain features because ...